Wednesday
11.13.2024
6:37 PM
Login form
Search
Calendar
«  December 2023  »
SuMoTuWeThFrSa
     12
3456789
10111213141516
17181920212223
24252627282930
31
Entries archive

My site

Main » 2023 » December » 17

Takeda Receives Positive CHMP Opinion for HYQVIA® as Maintenance Therapy in Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

OSAKA, Japan & CAMBRIDGE, Mass. - Friday, 15. December 2023


    If Approved, HYQVIA [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase] Would Offer an up to Once-Monthly Facilitated Subcutaneous At-Home or In-Office Treatment Option
    Positive Opinion Based on Phase 3 ADVANCE-CIDP 1 Study, Which Met its Primary Endpoint Demonstrating a Statistically Significant Reduction in Relapse Rate 1

 

(BUSINESS WIRE) -- Takeda (TSE:4502/NYSE:TAK) today announced the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of HYQVIA® [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase] in patients with chronic inflammatory demyeli ... Read more »

Views: 60 | Added by: africa-live | Date: 12.17.2023 | Comments (0)